StreetAlpha.app
Home › Stocks › TTRX

Turn Therapeutics Inc. (TTRX)

$8.10
▼ −6.31%
LAST CLOSE · NOV 20

Turn Therapeutics develops topical drug candidates for skin conditions and licenses wound care medical devices to partners. It last closed at $8.10 on Nov 20, down 6.31% on the day. The next earnings report for TTRX is expected around Tue, Mar 30, 2027, after the close. For the quarter ended Sep 2026, TTRX reported EPS of -$0.21. Over its last 5 reports the stock moved an average of 4.4% the session after earnings. Over the last 12 months TTRX insiders bought $109K of stock on the open market and sold $0, according to SEC Form 4 filings.

AI Auto Pilots
Is TTRX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold TTRX.

Key Stats

Last 12 months
Results
Net income
−$12.8M
EPS (diluted)
−$0.43
Valuation
Market cap
$247.5M
30.6M shares
P/E
–
No P/E while losing money
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$9.4M
At Sep 30
Debt
$7.3M
At Sep 30
Shareholder equity
$5.7M
Shares outstanding
30.6M
At Nov 6
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2024: −$1.8M−$1.8MFY2024FY2025: −$3.2M−$3.2MFY2025

From TTRX's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 9). Last 12 months adds up the four latest quarters.

Next report
Mar 30
Estimated date · After the close
Reported EPS
-$0.21
Quarter ended Sep 2026
Year ago EPS
-$0.07
Same quarter last year
Revenue
—
Last reported quarter
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.02Dec '24Mar 2025: -$0.01Mar '25Jun 2025: -$0.05Jun '25Sep 2025: -$0.07Sep '25Dec 2025: $0.01Dec '25Mar 2026: -$0.03Mar '26Jun 2026: -$0.20Jun '26Sep 2026: -$0.21Sep '26Latest -$0.21
Revenue by quarter
Not enough quarters on file yet.
How TTRX moved after its last 5 reports
Average move the session after a report ±4.4%
Nov 9, 2026Time not announced+3.3%
Aug 12, 2026After the close−6.5%
May 11, 2026After the close+2.6%
Mar 31, 2026After the close−2.7%
Nov 13, 2025Time not announced−7.0%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on TTRXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on TTRX
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on TTRX

Technical Analysis

TTRX · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold

The stock is 19% below its 20 day and 40% below its 50 day average. It is 9% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 35), near oversold. The nearest support is the Pivot S1 at $7.59, and the nearest resistance the Pivot at $8.39.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityHigh, 12.8%/day
Key levels
$16.4552 week high+103.1%
$11.3250 day average+39.8%
$10.49100 day average+29.5%
$10.48Swing high (Jul 21)+29.4%
$9.6620 day average+19.3%
$8.90Pivot R1+9.9%
$8.39Pivot+3.6%
$8.10Last close
$7.59Pivot S1−6.3%
$7.37200 day average−9.0%
$7.17Swing low (Jul 29)−11.5%
$2.5752 week low−68.3%
Indicators
RSI (14)34.95Weak, oversold below 30Neutral
MACD-0.67Below its signal lineBearish
Stochastic16.6Near the bottom of its rangeOversold
ADX (14)25.6Trending down
Williams %R-93.8Oversold below −80, overbought above −20Oversold
CCI (20)-134.7Oversold below −100, overbought above 100Oversold
Rate of change−14.6%Change over 10 sessionsBearish
ATR (14)$1.04Typical daily range, 12.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for TTRX

What happened before

See how TTRX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Whale Options Flow

90D
Whale options flow for TTRXHow many large options trades hit TTRX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

TTRX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲27 buying vs 7 selling
  • ▲Held by funds +3.8 pts
  • ▲Funds holding +14
  • ●Superinvestors: 1 added, 1 cut
  • ●Put/call not meaningful
Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding4329+48.3%
In funds' top 1000–
Held by funds7.6%3.8%+3.8 pts
New / increased16 / 1110 / 4+92.9%
Reduced / sold out4 / 32 / 2+75.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See TTRX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

TTRX Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$109K4 buys · 2 insiders
Sold$00 sales · 0 insiders
2025-12 bought $9KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Dec 12, 2025Zuraiz ChaudharySee RemarksBuy2,500$3.50$9K
Nov 24, 2025Arthur F GoldenDirectorBuy9,868$3.44$34K
Nov 21, 2025Arthur F GoldenDirectorBuy20,532$2.87$59K
Nov 21, 2025Zuraiz ChaudharySee RemarksBuy2,450$2.89$7K
Nov 17, 2025Zuraiz ChaudharySee RemarksBuy2,500$3.62$9K
Oct 23, 2025Abraham ChesedInsiderBuy14,286$4.60$66K
Every insider buy and sale for TTRX over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See TTRX insider trades →

From SEC Form 4 filings by TTRX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TTRX is in one of them and how their past TTRX trades turned out.

TTRX in the AI portfolios
Loading…

TTRX News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered TTRX in an article yet. Here's the latest on the wider market.

TTRX in the news

About Turn Therapeutics

Turn Therapeutics is a drug development company based in Westlake Village, California. It is developing GX-03, a topical treatment for inflammatory skin conditions, with programs aimed at moderate to severe eczema and nail fungus, known as onychomycosis. The company also licenses wound care and dermatitis medical devices to commercial partners, including Medline. Its drug candidate uses polyhexanide, a polymer with a long history of use in wound care.

Headquarters
Westlake Village, CA